A Randomized Open-Labeled Trial of Methotrexate as a Steroid-Sparing Agent for Patients With Generalized Myasthenia Gravis

BACKGROUND AND PURPOSE: Two clinical trials assessing the steroid-sparing effect of methotrexate (MTX) yielded conflicting results. Our objective was to investigate whether MTX would show a steroid-sparing effect in the treatment of generalized myasthenia gravis (MG) patients who fitted Myasthenia G...

Descripción completa

Detalles Bibliográficos
Autores principales: Di, Li, Shen, Faxiu, Wen, Xinmei, Lu, Yan, Zhu, Wenjia, Wang, Min, Da, Yuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971191/
https://www.ncbi.nlm.nih.gov/pubmed/35371086
http://dx.doi.org/10.3389/fimmu.2022.839075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971191/
https://www.ncbi.nlm.nih.gov/pubmed/35371086
http://dx.doi.org/10.3389/fimmu.2022.839075

Ejemplares similares